Janne Janne Lehtiö Karolinska Institutet and SCILIFELAB Sweden

Professor Janne Lehtiö and the LehtiöLab focuses on proteomics and proteogenomics to gain new knowledge on molecular phenotype of cancer to apply the gained knowledge on improving personalized medicine. He received a faculty professor position in Medical Proteomics at Karolinska Institutet in 2015 and since 2021 has shared clinical appointment at Karolinska University Hospital as head of clinical proteomics unit. Since 2008 Lehtiö has been principle investigator at Dept. of Oncology and Pathology at Karolinska Institutet (KI), Sweden, currently leading the cancer proteogenomics research group of 40 researchers. Previously, at 2004, Dr. Lehtiö was appointed as director of the Karolinska University Hospital’s clinical proteomics facility and since 2010 he is director of the clinical proteomics mass spectrometry facility at the national research center Science for Life Laboratory t Stockholm.